| For: | Neperud J, Mahvash A, Garg N, Murthy R, Szklaruk J. Can imaging patterns of neuroendocrine hepatic metastases predict response yttruim-90 radioembolotherapy? World J Radiol 2013; 5(6): 241-247 [PMID: 23807902 DOI: 10.4329/wjr.v5.i6.241] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v5/i6/241.htm |
| Number | Citing Articles |
| 1 |
Ananya Panda, Ishan Garg, Geoffrey B Johnson, Mark J Truty, Thorvardur R Halfdanarson, Ajit H Goenka. Molecular radionuclide imaging of pancreatic neoplasms. The Lancet Gastroenterology & Hepatology 2019; 4(7) doi: 10.1016/S2468-1253(19)30081-0
|
| 2 |
Markus Galler, Julian M. M. Rogasch, Kai Huang, Henning Jann, Kristina Plehm, Christoph Wetz, Holger Amthauer. Prognostic Value of the Largest Lesion Size for Progression-Free Survival in Patients with NET Undergoing Salvage PRRT with [177Lu]Lu-DOTATOC. Cancers 2022; 14(7) doi: 10.3390/cancers14071768
|
| 3 |
Louis de Mestier, Magaly Zappa, Olivia Hentic, Valérie Vilgrain, Philippe Ruszniewski. Liver transarterial embolizations in metastatic neuroendocrine tumors. Reviews in Endocrine and Metabolic Disorders 2017; 18(4) doi: 10.1007/s11154-017-9431-2
|
| 4 |
Thomas C. Lauenstein, Juliane Schelhorn, Sonja Kinner. Clinical Nuclear Medicine. 2020; doi: 10.1007/978-3-030-39457-8_37
|
| 5 |
Ghassan El-Haddad, Jonathan Strosberg. Radioembolization for Metastatic Neuroendocrine Tumors. Digestive Disease Interventions 2021; 5(02) doi: 10.1055/s-0041-1729755
|
| 6 |
Mark Kidd, Irvin M. Modlin, Lisa Bodei, Ignat Drozdov. Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology. Cellular and Molecular Gastroenterology and Hepatology 2015; 1(2) doi: 10.1016/j.jcmgh.2014.12.008
|
| 7 |
Naveen Rajamohan, Hala Khasawneh, Aparna Singh, Garima Suman, Geoffrey B. Johnson, Shounak Majumder, Thorvardur R. Halfdanarson, Ajit H. Goenka. PET/CT and PET/MRI in neuroendocrine neoplasms. Abdominal Radiology 2022; 47(12) doi: 10.1007/s00261-022-03516-2
|
| 8 |
Marianne Pavel, Henning Jann, Vikas Prasad, Ignat Drozdov, Irvin M. Modlin, Mark Kidd. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive. Neuroendocrinology 2017; 104(2) doi: 10.1159/000446025
|
| 9 |
Irvin M Modlin, Ignat Drozdov, Daniele Alaimo, Stephen Callahan, Nancy Teixiera, Lisa Bodei, Mark Kidd. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection. Endocrine-Related Cancer 2014; 21(4) doi: 10.1530/ERC-14-0190
|
| 10 |
Irvin M. Modlin, Mark Kidd, Anna Malczewska, Ignat Drozdov, Lisa Bodei, Somer Matar, Kyung-Min Chung. The NETest. Endocrinology and Metabolism Clinics of North America 2018; 47(3) doi: 10.1016/j.ecl.2018.05.002
|
| 11 |
Rocio Garcia-Carbonero, Roberto Garcia-Figueiras, Alberto Carmona-Bayonas, Isabel Sevilla, Alex Teule, Maria Quindos, Enrique Grande, Jaume Capdevila, Javier Aller, Javier Arbizu, Paula Jimenez-Fonseca. Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development. Cancer and Metastasis Reviews 2015; 34(4) doi: 10.1007/s10555-015-9598-5
|
| 12 |
Julian Gertner, Marina Tsoli, Aimee R. Hayes, Luke Furtado O’Mahony, Faidon-Marios Laskaratos, Thomas Glover, Priyesh Karia, Mohsin F. Butt, Oliver Eastwood, Dalvinder Mandair, Martyn Caplin, Christos Toumpanakis. The Clinical Utility of the NETest in Patients with Small Intestinal Neuroendocrine Neoplasms (Si-NENs): A “Real-Life” Study. Cancers 2024; 16(14) doi: 10.3390/cancers16142506
|
| 13 |
Strosberg Jonathan, Ghassan El-Haddad, Taymeyah Al-Toubah, Diane Reidy-Lagunes, Etay Ziv, Armeen Mahvash, Arvind Dasari, Philip A. Philip, Michael C. Soulen. Radioembolization Versus Bland or Chemoembolization for Liver-Dominant Neuroendocrine Tumors: Is It an Either/Or Question?. Journal of Nuclear Medicine 2021; 62(12) doi: 10.2967/jnumed.121.263041
|